Toxoplasma gondii Oocyst–specific Antibodies and Source of Infection
Claudia A. Muñoz-Zanzi , Paulina Fry, Blaz Lesina, and Dolores Hill
Author affiliations: Author affiliations: University of Minnesota, Minneapolis, Minnesota, USA (C. Muñoz-Zanzi); Universidad Austral de Chile, Valdivia, Chile (C. Muñoz-Zanzi, P. Fry, B. Lesina); United States Department of Agriculture, Beltsville, Maryland, USA (D. Hill)
Figure. Detection of Toxoplasma gondii in 494 low-income pregnant women from Valdivia Province, Chile. *<15%, indicates acute infection; †15%–30%, indicates possible infection within <6 mo (4 samples from recently infected women were not tested for SSP antibodies); ‡>30%, excludes recent (within 3 mo) infection (9 samples from women with chronic infection were not tested for SSP antibodies). –, negative; +, positive; Ig, immunoglobulin; SSP, sporozoite-specific protein antibodies.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.